- Home
- ZNTL vs MHH Comparison
ZNTL vs MHH Comparison
Compare ZNTL & MHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- MHH
- Stock Information
- Founded
- ZNTL 2014
- MHH 1986
- Country
- ZNTL United States
- MHH United States
- Employees
- ZNTL N/A
- MHH N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- MHH Professional Services
- Sector
- ZNTL Health Care
- MHH Consumer Discretionary
- Exchange
- ZNTL Nasdaq
- MHH Nasdaq
- Market Cap
- ZNTL 134.7M
- MHH 154.8M
- IPO Year
- ZNTL 2020
- MHH N/A
- Fundamental
- Price
- ZNTL $2.32
- MHH $11.58
- Analyst Decision
- ZNTL Buy
- MHH
- Analyst Count
- ZNTL 8
- MHH 0
- Target Price
- ZNTL $8.53
- MHH N/A
- AVG Volume (30 Days)
- ZNTL 2.7M
- MHH 20.9K
- Earning Date
- ZNTL 03-04-2025
- MHH 02-19-2025
- Dividend Yield
- ZNTL N/A
- MHH N/A
- EPS Growth
- ZNTL N/A
- MHH N/A
- EPS
- ZNTL N/A
- MHH 0.28
- Revenue
- ZNTL $40,560,000.00
- MHH $198,943,000.00
- Revenue This Year
- ZNTL N/A
- MHH $0.53
- Revenue Next Year
- ZNTL N/A
- MHH $1.53
- P/E Ratio
- ZNTL N/A
- MHH $41.36
- Revenue Growth
- ZNTL N/A
- MHH N/A
- 52 Week Low
- ZNTL $1.61
- MHH $7.15
- 52 Week High
- ZNTL $18.07
- MHH $16.00
- Technical
- Relative Strength Index (RSI)
- ZNTL 49.24
- MHH 37.06
- Support Level
- ZNTL $2.37
- MHH $11.84
- Resistance Level
- ZNTL $2.36
- MHH $13.25
- Average True Range (ATR)
- ZNTL 0.25
- MHH 0.87
- MACD
- ZNTL 0.08
- MHH -0.11
- Stochastic Oscillator
- ZNTL 69.27
- MHH 7.67
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as an Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.
About MHH Mastech Digital Inc
Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.